Melhores Câncer uterino médicos - TOP-89 médicos

• O Dr. Bülent Karagöz é especializado no tratamento do câncer uterino, utilizando cirurgia, radioterapia, quimioterapia, hormonoterapia e terapia direcionada.
• O Dr. Bülent Karagöz tem experiência de prática internacional em instituições médicas na Turquia, no Comando da KFOR da OTAN e no Comando das Forças de Paz Cipriota Turca.
• Com mais de 20 anos de experiência em oncologia, o Dr. Karagöz realizou extensas pesquisas em biologia tumoral e imunologia.
• Como membro da Associação Turca de Oncologia Médica, o Dr. Karagöz segue os mais altos padrões médicos.
• Ele também é professor na Faculdade de Medicina da Universidade Okan de Istambul, onde contribui para os avanços acadêmicos e clínicos.

A Dra. Esra Ozbasli é ginecologista-obstetra certificada e cirurgiã de estética genital. Ela tem mais de 21 anos de experiência e é uma das principais especialistas de Istambul. A Dra. Ozbasli é reconhecida por suas habilidades em procedimentos ginecológicos minimamente invasivos e estéticos genitais. Ela realiza cirurgia robótica e ginecologia estética com técnicas avançadas.

Ela possui certificações em Estética Genital, Ginecologia Estética e Cirurgia Robótica da Vinci. A Dra. Ozbasli também é acreditada pela ECFMG. Ela publicou muitos artigos em revistas internacionais e formou outros especialistas. Seu trabalho demonstra um forte compromisso com a pesquisa e educação. A Dra. Ozbasli fala inglês fluentemente e oferece cuidados centrados no paciente. Ela utiliza a tecnologia mais recente para alcançar os melhores resultados para seus pacientes.

Ela trabalha como especialista em medicina interna e oncologia médica no Centro Médico Anadolu desde 2021.
 

• Mustafa Solak, M.D. é especializado em tratamento de câncer uterino utilizando métodos cirúrgicos e quimioterapêuticos avançados.
• As opções de tratamento padrão para o câncer uterino incluem cirurgia, radioterapia, quimioterapia, terapia hormonal e terapia alvo.
• Formação internacional no University of Texas MD Anderson Cancer Center, EUA.
• Graduado pela Faculdade de Medicina da Universidade de Hacettepe; residência no Hospital de Ensino e Pesquisa Sisli Etfal de Istambul.
• Associações profissionais: Membro do Instituto do Câncer da Universidade de Hacettepe, com foco em oncologia.

• Especializa-se no tratamento do câncer uterino através de cirurgia, radioterapia, quimioterapia e terapia alvo.
• O médico possui experiência de prática internacional em clínicas na Turquia, EUA, Israel e Reino Unido.
• Certificado pela Sociedade Europeia de Oncologia Médica (ESMO).
• Membro da ESMO e da Escola Europeia de Oncologia (ESO).
• Idiomas falados: Inglês, Russo (nível B1), Turco.

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

A Prof.ª Hale Başak Çağlar é diretora de oncologia de radiação e especialista no tratamento de câncer de mama, pulmão, pâncreas, próstata e ossos. Ela é altamente qualificada, tendo obtido sua formação na Universidade de Gazi, Universidade de Marmara e Universidade de Medipol, e é membro de diversas sociedades, como a Sociedade Americana de Oncologia de Radiação Terapêutica, a Sociedade Europeia de Oncologia de Radiação Terapêutica, a Organização Europeia para Pesquisa e Tratamento do Câncer e a Sociedade de Radiocirurgia.

1.Bachelor’s degree
- Doctor of medicine, Rangsit university.

2.Master’s degree

>Medical and health science degree
- Professional master’s degree in clinical nutrition in medicine.
- Professional master’s degree in integrative medicine.

>Management degree
- Professional master’s degree in hospital and health services management.

3.Doctorate degree
- Doctorate in psychology (candidate).

4.Diploma
- American Bord of nutritional wellness.
- American naturopathic certification board.

- Certified integrative oncology physician, American institute of integrative oncology.

- Certified fertility wellness physician.

- Certified CBT-I physician.

- Advanced nutritional wellness, IFNW.

-Biochemical and clinical analysis diploma.

- Functional gastroenterology and pediatric food allergies diploma.

- IV nutrition diploma, IFNW.

-Medicinal herbology diploma, IFNW.

Um dos melhores especialistas em câncer na Europa, educador e pesquisador de câncer, Presidente do Central European Cooperative Oncology Group (CECOG).
Publicou mais de 600 artigos científicos sobre o tratamento do câncer.

Professor Dr. Mehmet Karaca

Data de Nascimento: 1971, 

Local de Nascimento: Antália. 

Idiomas Estrangeiros Conhecidos: Inglês

Interesses Médicos Centro de Câncer Escolas / formações Professor de Ginecologia e Obstetrícia

Interesses Médicos cânceres ginecológicos Gravidez gravidez de alto risco cirurgia laparoscópica Uroginecologia estética genital infertilidade fertilização in vitro

 Escolas / formações

1993 - Graduação em Medicina na Universidade Akdeniz    

1993 - Mestrado em Medicina na Universidade Akdeniz     1999 - Doutoramento em Obstetrícia e Ginecologia, Universidade de Dicle    

2011 - Especialização em Cirurgia Oncológica Ginecológica Ministério da Saúde experiências

2002 - 2005 - Universidade de Gaziantep - faculdade de medicina - membro da faculdade

2006 - 2010 - Universidade de Kafkas - faculdade de medicina - membro da faculdade

2010 - 2014 - Hospital de Treinamento e Pesquisa de Antália - chefe clínico

2014 - 2021 - Hospital Medstar Yıldız

2018 - 2021 - Universidade Gelisim - membro da faculdade

2021 - presente - Complexo Hospitalar Medical Park Antalya

Dr. Ofer Merimsly é o melhor médico em sarcoma, linfoma e câncer de pulmão em Israel e no mundo. Também é especialista no tratamento cirúrgico Whipple para pacientes com câncer de pâncreas. Chefe do Centro Nacional para sarcomas ósseos e de tecidos moles do Centro Médico Tel Aviv Sourasky (Ichilov).

Especialidade:

• Tratamento de todos os tipos de câncer de pulmão e órgãos torácicos
• Tratamento de todos os tipos de sarcomas ósseos e de tecidos moles
• Tratamento de tumores estromais do trato gastrointestinal

Educação e especialização:

• Ensino superior em medicina, formado pela Faculdade de Medicina da Universidade Hebraica de Jerusalém, Israel
• Residência em Oncologia Geral e Radioterapia
• Treinamento em radioterapia e braquiterapia no New York Hospital, EUA
• Curso de atualização especial para o tratamento de tumores do esqueleto e tecidos moles, Paris, França

Membro:

• Presidente da Sociedade de Oncologistas e Radioterapeutas de Israel
• Sociedade Americana de Câncer Científico
• Organização médica científica europeia
• Sociedade Europeia de Oncologia do sistema musculoesquelético
• Sociedade Internacional para o tratamento de tumores do tecido conjuntivo

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

• Prof. Elke Jaeger, Chefe de Oncologia e Hematologia no Nordwest, é especialista no tratamento do câncer uterino.
• Opções padrão de tratamento: cirurgia, radioterapia, quimioterapia, terapia hormonal, terapia direcionada.
• A médica possui experiência internacional em instituições médicas na Alemanha, nos EUA e na Suíça.
• Classificada como uma das melhores oncologistas alemãs pelo rating da Focus.
• Associações profissionais: Sociedade Alemã de Hematologia e Oncologia, Sociedade Europeia de Oncologia Médica.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students